 | • レポートコード：MRC2-11QY03646 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は癌性食欲不振-悪液質症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（NEO-1940、C-1889、DLN-101、Foxo1-nRNA、AVGN-7、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別癌性食欲不振-悪液質症候群治療薬の競争状況、市場シェア ・世界の癌性食欲不振-悪液質症候群治療薬市場：種類別市場規模 2015年-2020年（NEO-1940、C-1889、DLN-101、Foxo1-nRNA、AVGN-7、その他） ・世界の癌性食欲不振-悪液質症候群治療薬市場：種類別市場規模予測 2021年-2026年（NEO-1940、C-1889、DLN-101、Foxo1-nRNA、AVGN-7、その他） ・世界の癌性食欲不振-悪液質症候群治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の癌性食欲不振-悪液質症候群治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の癌性食欲不振-悪液質症候群治療薬市場分析：米国、カナダ ・ヨーロッパの癌性食欲不振-悪液質症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの癌性食欲不振-悪液質症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の癌性食欲不振-悪液質症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの癌性食欲不振-悪液質症候群治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acacia Pharma Ltd、Aeterna Zentaris Inc、Aphios Corp、Incyte Corp、Lakewood-Amedex Inc、Novartis AG、Obexia AG、PsiOxus Therapeutics Ltd、RaQualia Pharma Inc、Viking Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Cancer Anorexia-Cachexia Syndrome Drug Market
The global Cancer Anorexia-Cachexia Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cancer Anorexia-Cachexia Syndrome Drug Scope and Market Size
Cancer Anorexia-Cachexia Syndrome Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Anorexia-Cachexia Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Anorexia-Cachexia Syndrome Drug market is segmented into
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
Segment by Application, the Cancer Anorexia-Cachexia Syndrome Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Cancer Anorexia-Cachexia Syndrome Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Anorexia-Cachexia Syndrome Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Anorexia-Cachexia Syndrome Drug Market Share Analysis
Cancer Anorexia-Cachexia Syndrome Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Anorexia-Cachexia Syndrome Drug business, the date to enter into the Cancer Anorexia-Cachexia Syndrome Drug market, Cancer Anorexia-Cachexia Syndrome Drug product introduction, recent developments, etc.
The major vendors covered:
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
1 Study Coverage
1.1 Cancer Anorexia-Cachexia Syndrome Drug Product Introduction
1.2 Market Segments
1.3 Key Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Type
1.4.2 NEO-1940
1.4.3 C-1889
1.4.4 DLN-101
1.4.5 Foxo1-nRNA
1.4.6 AVGN-7
1.4.7 Others
1.5 Market by Application
1.5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue 2015-2026
2.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales 2015-2026
2.2 Global Cancer Anorexia-Cachexia Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Anorexia-Cachexia Syndrome Drug Competitor Landscape by Players
3.1 Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers
3.1.1 Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers (2015-2020)
3.1.2 Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers
3.2.1 Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Anorexia-Cachexia Syndrome Drug Revenue in 2019
3.2.5 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Anorexia-Cachexia Syndrome Drug Price by Manufacturers
3.4 Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Anorexia-Cachexia Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type (2015-2020)
4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020)
4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2015-2020)
4.1.3 Cancer Anorexia-Cachexia Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Anorexia-Cachexia Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application (2015-2020)
5.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020)
5.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2015-2020)
5.1.3 Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2015-2020)
5.2 Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cancer Anorexia-Cachexia Syndrome Drug by Country
6.1.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
6.1.2 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Type
6.3 North America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Cancer Anorexia-Cachexia Syndrome Drug by Country
7.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
7.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Type
7.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug by Region
8.1.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region
8.1.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Type
8.3 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug by Country
9.1.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
9.1.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Type
9.3 Central & South America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug by Country
10.1.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
10.1.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Acacia Pharma Ltd
11.1.1 Acacia Pharma Ltd Corporation Information
11.1.2 Acacia Pharma Ltd Description and Business Overview
11.1.3 Acacia Pharma Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.1.5 Acacia Pharma Ltd Related Developments
11.2 Aeterna Zentaris Inc
11.2.1 Aeterna Zentaris Inc Corporation Information
11.2.2 Aeterna Zentaris Inc Description and Business Overview
11.2.3 Aeterna Zentaris Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.2.5 Aeterna Zentaris Inc Related Developments
11.3 Aphios Corp
11.3.1 Aphios Corp Corporation Information
11.3.2 Aphios Corp Description and Business Overview
11.3.3 Aphios Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.3.5 Aphios Corp Related Developments
11.4 Incyte Corp
11.4.1 Incyte Corp Corporation Information
11.4.2 Incyte Corp Description and Business Overview
11.4.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.4.5 Incyte Corp Related Developments
11.5 Lakewood-Amedex Inc
11.5.1 Lakewood-Amedex Inc Corporation Information
11.5.2 Lakewood-Amedex Inc Description and Business Overview
11.5.3 Lakewood-Amedex Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.5.5 Lakewood-Amedex Inc Related Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Description and Business Overview
11.6.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.6.5 Novartis AG Related Developments
11.7 Obexia AG
11.7.1 Obexia AG Corporation Information
11.7.2 Obexia AG Description and Business Overview
11.7.3 Obexia AG Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.7.5 Obexia AG Related Developments
11.8 PsiOxus Therapeutics Ltd
11.8.1 PsiOxus Therapeutics Ltd Corporation Information
11.8.2 PsiOxus Therapeutics Ltd Description and Business Overview
11.8.3 PsiOxus Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.8.5 PsiOxus Therapeutics Ltd Related Developments
11.9 RaQualia Pharma Inc
11.9.1 RaQualia Pharma Inc Corporation Information
11.9.2 RaQualia Pharma Inc Description and Business Overview
11.9.3 RaQualia Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.9.5 RaQualia Pharma Inc Related Developments
11.10 Viking Therapeutics Inc
11.10.1 Viking Therapeutics Inc Corporation Information
11.10.2 Viking Therapeutics Inc Description and Business Overview
11.10.3 Viking Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.10.5 Viking Therapeutics Inc Related Developments
11.1 Acacia Pharma Ltd
11.1.1 Acacia Pharma Ltd Corporation Information
11.1.2 Acacia Pharma Ltd Description and Business Overview
11.1.3 Acacia Pharma Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
11.1.5 Acacia Pharma Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Projections by Region
12.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast (2021-2026)
12.2.2 North America: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Anorexia-Cachexia Syndrome Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Anorexia-Cachexia Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cancer Anorexia-Cachexia Syndrome Drug Market Segments
Table 2. Ranking of Global Top Cancer Anorexia-Cachexia Syndrome Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of NEO-1940
Table 5. Major Manufacturers of C-1889
Table 6. Major Manufacturers of DLN-101
Table 7. Major Manufacturers of Foxo1-nRNA
Table 8. Major Manufacturers of AVGN-7
Table 9. Major Manufacturers of Others
Table 10. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Anorexia-Cachexia Syndrome Drug as of 2019)
Table 19. Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Price (2015-2020) (USD/Pcs)
Table 22. Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
Table 24. Date of International Manufacturers Enter into Cancer Anorexia-Cachexia Syndrome Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2015-2020)
Table 28. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2015-2020)
Table 30. Cancer Anorexia-Cachexia Syndrome Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2015-2020)
Table 33. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 35. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Table 39. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Table 73. Acacia Pharma Ltd Corporation Information
Table 74. Acacia Pharma Ltd Description and Major Businesses
Table 75. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Acacia Pharma Ltd Product
Table 77. Acacia Pharma Ltd Recent Development
Table 78. Aeterna Zentaris Inc Corporation Information
Table 79. Aeterna Zentaris Inc Description and Major Businesses
Table 80. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Aeterna Zentaris Inc Product
Table 82. Aeterna Zentaris Inc Recent Development
Table 83. Aphios Corp Corporation Information
Table 84. Aphios Corp Description and Major Businesses
Table 85. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Aphios Corp Product
Table 87. Aphios Corp Recent Development
Table 88. Incyte Corp Corporation Information
Table 89. Incyte Corp Description and Major Businesses
Table 90. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Incyte Corp Product
Table 92. Incyte Corp Recent Development
Table 93. Lakewood-Amedex Inc Corporation Information
Table 94. Lakewood-Amedex Inc Description and Major Businesses
Table 95. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Lakewood-Amedex Inc Product
Table 97. Lakewood-Amedex Inc Recent Development
Table 98. Novartis AG Corporation Information
Table 99. Novartis AG Description and Major Businesses
Table 100. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Novartis AG Product
Table 102. Novartis AG Recent Development
Table 103. Obexia AG Corporation Information
Table 104. Obexia AG Description and Major Businesses
Table 105. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Obexia AG Product
Table 107. Obexia AG Recent Development
Table 108. PsiOxus Therapeutics Ltd Corporation Information
Table 109. PsiOxus Therapeutics Ltd Description and Major Businesses
Table 110. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. PsiOxus Therapeutics Ltd Product
Table 112. PsiOxus Therapeutics Ltd Recent Development
Table 113. RaQualia Pharma Inc Corporation Information
Table 114. RaQualia Pharma Inc Description and Major Businesses
Table 115. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. RaQualia Pharma Inc Product
Table 117. RaQualia Pharma Inc Recent Development
Table 118. Viking Therapeutics Inc Corporation Information
Table 119. Viking Therapeutics Inc Description and Major Businesses
Table 120. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Viking Therapeutics Inc Product
Table 122. Viking Therapeutics Inc Recent Development
Table 123. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 124. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. North America: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Europe: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 132. Asia Pacific: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Latin America: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Middle East and Africa: Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Cancer Anorexia-Cachexia Syndrome Drug Players
Table 141. Cancer Anorexia-Cachexia Syndrome Drug Customers List
Table 142. Cancer Anorexia-Cachexia Syndrome Drug Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Product Picture
Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. NEO-1940 Product Picture
Figure 4. C-1889 Product Picture
Figure 5. DLN-101 Product Picture
Figure 6. Foxo1-nRNA Product Picture
Figure 7. AVGN-7 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Cancer Anorexia-Cachexia Syndrome Drug Report Years Considered
Figure 14. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2019
Figure 19. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region in 2019
Figure 21. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Cancer Anorexia-Cachexia Syndrome Drug Revenue in 2019
Figure 23. Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2019
Figure 26. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type in 2019
Figure 28. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Price Range (2015-2020)
Figure 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2019
Figure 31. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application in 2019
Figure 33. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2019
Figure 36. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2019
Figure 42. North America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2019
Figure 43. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2019
Figure 46. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2019
Figure 47. Germany Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2019
Figure 58. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2019
Figure 59. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region in 2019
Figure 63. China Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2019
Figure 86. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2019
Figure 87. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2019
Figure 90. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2019
Figure 98. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2019
Figure 111. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
がん悪液質の世界市場（～2026年） Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. Market Analysis and Insights: Global Cancer Cachexia Market The global Cancer Cachexia mark…- 神経性食欲不振症治療の世界市場（～2026年） Anorexia nervosa is a dietary disorder or eating disorder portrayed by an irregular low body weight, risky fear of putting on weight and a misshaped view of body weight. Individuals with anorexia put a high incentive on controlling their weight and shape, utilizing outrageous endeavors that have a t…
- レノックス・ガストー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lennox-Gastaut Syndrome Drug Market The global Lennox-Gastaut Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lennox-Gastaut Syndrome Drug Scope and Market Size Lennox…
- 好酸球増加症候群薬の世界市場（～2026年） Market Analysis and Insights: Global Hypereosinophilic Syndrome Drug Market The global Hypereosinophilic Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hypereosinophilic Syndrome Drug Scope and Market Si…
- 基底細胞母斑症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Basal Cell Nevus Syndrome Drug Market The global Basal Cell Nevus Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Basal Cell Nevus Syndrome Drug Scope and Market Size …